On Thursday, May 14, the Meso Foundation interviewed Dr. Charles Simone and Dr. Evan Alley of the University of Pennsylvania Medicine during the Meet the Mesothelioma Experts series. The session was part of a series of interviews focusing on mesothelioma centers of excellence. Drs. Simone and Alley were interviewed by the Meso Foundation’s executive director, Mary Hesdorffer, with whom they discussed the mesothelioma program at the University of Pennsylvania Medicine.
The full interview is now available on demand on the Meso Foundation’s website at curemeso.org/experts.
Drs. Alley and Simone are the co-directors of the Penn Mesothelioma and Pleural Program. Dr. Alley is a medical oncologist and is the leading investigator in the PD-1 inhibitor trial that has recently made big news in mesothelioma. Read more about the trial here. Dr. Simone treats patients with malignant pleural mesothelioma with photon and proton radiation therapy and photodynamic therapy (PDT). He is a National Institutes of Health and Department of Defense funded investigator who performs clinical and translational research investigating the novel use of proton therapy and PDT as definitive therapy and as part of multi-modality therapy for mesothelioma.
As part of the Meet the Mesothelioma Experts series, the Meso Foundation invites specialists in the field of mesothelioma to discuss their current research interests as well as promising developments in the treatment of mesothelioma.
You can listen to this interview and other previous Meet the Mesothelioma Experts sessions at curemeso.org/experts.
